Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127576561 | 12757656 | 1 | I | 20150130 | 20150709 | 20160919 | 20160919 | EXP | US-ROCHE-1606364 | ROCHE | 42.00 | YR | F | Y | 106.46000 | KG | 20160919 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127576561 | 12757656 | 1 | PS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 2130 | MG | SOLUTION FOR INFUSION | |||||||
127576561 | 12757656 | 2 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 2130 | MG | SOLUTION FOR INFUSION | |||||||
127576561 | 12757656 | 3 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 2130 | MG | SOLUTION FOR INFUSION | |||||||
127576561 | 12757656 | 4 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1065 | MG | SOLUTION FOR INFUSION | |||||||
127576561 | 12757656 | 5 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 2130 | MG | SOLUTION FOR INFUSION | |||||||
127576561 | 12757656 | 6 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1597.5 | MG | SOLUTION FOR INFUSION | |||||||
127576561 | 12757656 | 7 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1597.5 | MG | SOLUTION FOR INFUSION | |||||||
127576561 | 12757656 | 8 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1597.5 | MG | SOLUTION FOR INFUSION | |||||||
127576561 | 12757656 | 9 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1597.5 | MG | SOLUTION FOR INFUSION | |||||||
127576561 | 12757656 | 10 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1597.5 | MG | SOLUTION FOR INFUSION | |||||||
127576561 | 12757656 | 11 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1597.5 | MG | SOLUTION FOR INFUSION | |||||||
127576561 | 12757656 | 12 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1597.5 | MG | SOLUTION FOR INFUSION | |||||||
127576561 | 12757656 | 13 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1597.5 | MG | SOLUTION FOR INFUSION | |||||||
127576561 | 12757656 | 14 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1598 | MG | SOLUTION FOR INFUSION | |||||||
127576561 | 12757656 | 15 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1431 | MG | SOLUTION FOR INFUSION | |||||||
127576561 | 12757656 | 16 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1431 | MG | SOLUTION FOR INFUSION | |||||||
127576561 | 12757656 | 17 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1431 | MG | SOLUTION FOR INFUSION | |||||||
127576561 | 12757656 | 18 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1431 | MG | SOLUTION FOR INFUSION | |||||||
127576561 | 12757656 | 19 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1431 | MG | SOLUTION FOR INFUSION | |||||||
127576561 | 12757656 | 20 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1431 | MG | SOLUTION FOR INFUSION | |||||||
127576561 | 12757656 | 21 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1431 | MG | SOLUTION FOR INFUSION | |||||||
127576561 | 12757656 | 22 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1431 | MG | SOLUTION FOR INFUSION | |||||||
127576561 | 12757656 | 23 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1431 | MG | SOLUTION FOR INFUSION | |||||||
127576561 | 12757656 | 24 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1431 | MG | SOLUTION FOR INFUSION | |||||||
127576561 | 12757656 | 25 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1431 | MG | SOLUTION FOR INFUSION | |||||||
127576561 | 12757656 | 26 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1431 | MG | SOLUTION FOR INFUSION | |||||||
127576561 | 12757656 | 27 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1431 | MG | SOLUTION FOR INFUSION | |||||||
127576561 | 12757656 | 28 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1431 | MG | SOLUTION FOR INFUSION | |||||||
127576561 | 12757656 | 29 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1431 | MG | SOLUTION FOR INFUSION | |||||||
127576561 | 12757656 | 30 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1431 | MG | SOLUTION FOR INFUSION | |||||||
127576561 | 12757656 | 31 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1431 | MG | SOLUTION FOR INFUSION | |||||||
127576561 | 12757656 | 32 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1431 | MG | SOLUTION FOR INFUSION | |||||||
127576561 | 12757656 | 33 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1431 | MG | SOLUTION FOR INFUSION | |||||||
127576561 | 12757656 | 34 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1431 | MG | SOLUTION FOR INFUSION | |||||||
127576561 | 12757656 | 35 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1431 | MG | SOLUTION FOR INFUSION | |||||||
127576561 | 12757656 | 36 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1431 | MG | SOLUTION FOR INFUSION | |||||||
127576561 | 12757656 | 37 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1431 | MG | SOLUTION FOR INFUSION | |||||||
127576561 | 12757656 | 38 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1431 | MG | SOLUTION FOR INFUSION | |||||||
127576561 | 12757656 | 39 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1431 | MG | SOLUTION FOR INFUSION | |||||||
127576561 | 12757656 | 40 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1431 | MG | SOLUTION FOR INFUSION | |||||||
127576561 | 12757656 | 41 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1431 | MG | SOLUTION FOR INFUSION | |||||||
127576561 | 12757656 | 42 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1431 | MG | SOLUTION FOR INFUSION | |||||||
127576561 | 12757656 | 43 | SS | VELIPARIB | VELIPARIB | 1 | Oral | U | 0 | 4160 | MG | BID | |||||||
127576561 | 12757656 | 44 | SS | VELIPARIB | VELIPARIB | 1 | Oral | U | 0 | 4160 | MG | BID | |||||||
127576561 | 12757656 | 45 | SS | VELIPARIB | VELIPARIB | 1 | Oral | U | 0 | 4180 | MG | BID | |||||||
127576561 | 12757656 | 46 | SS | VELIPARIB | VELIPARIB | 1 | Oral | U | 0 | 1680 | MG | BID | |||||||
127576561 | 12757656 | 47 | SS | VELIPARIB | VELIPARIB | 1 | Oral | U | 0 | 1680 | MG | BID | |||||||
127576561 | 12757656 | 48 | SS | CARBOPLATIN. | CARBOPLATIN | 1 | Intravenous (not otherwise specified) | DATE OF MOST RECENT DOSE PRIOR TO SAE:27/DEC/2013, OVER 30 MINUTES ON DAY 1 | U | 0 | |||||||||
127576561 | 12757656 | 49 | SS | LIPOSOMAL DOXORUBICIN | DOXORUBICIN HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | DATE OF MOST RECENT DOSE PRIOR TO SAE:27/12/2013, OVER 1 HOUR ON DAY 1 | U | 0 | 30 | MG/M**2 | |||||||
127576561 | 12757656 | 50 | SS | LISINOPRIL. | LISINOPRIL | 1 | Unknown | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127576561 | 12757656 | 1 | Ovarian cancer |
127576561 | 12757656 | 43 | Ovarian cancer |
127576561 | 12757656 | 48 | Ovarian cancer |
127576561 | 12757656 | 49 | Ovarian cancer |
127576561 | 12757656 | 50 | Ovarian cancer |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127576561 | 12757656 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127576561 | 12757656 | Anaemia | |
127576561 | 12757656 | Hypertension | |
127576561 | 12757656 | Hypocalcaemia | |
127576561 | 12757656 | Hypokalaemia | |
127576561 | 12757656 | Neutrophil count decreased | |
127576561 | 12757656 | Platelet count decreased | |
127576561 | 12757656 | Proteinuria |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127576561 | 12757656 | 1 | 20130802 | 0 | ||
127576561 | 12757656 | 2 | 20130830 | 0 | ||
127576561 | 12757656 | 3 | 20130927 | 0 | ||
127576561 | 12757656 | 4 | 20131122 | 0 | ||
127576561 | 12757656 | 5 | 20131227 | 0 | ||
127576561 | 12757656 | 6 | 20140207 | 0 | ||
127576561 | 12757656 | 7 | 20140228 | 0 | ||
127576561 | 12757656 | 8 | 20140321 | 0 | ||
127576561 | 12757656 | 9 | 20140411 | 0 | ||
127576561 | 12757656 | 10 | 20140502 | 0 | ||
127576561 | 12757656 | 11 | 20140523 | 0 | ||
127576561 | 12757656 | 12 | 20140613 | 0 | ||
127576561 | 12757656 | 13 | 20140711 | 0 | ||
127576561 | 12757656 | 14 | 20140801 | 0 | ||
127576561 | 12757656 | 15 | 20140822 | 0 | ||
127576561 | 12757656 | 16 | 20140919 | 0 | ||
127576561 | 12757656 | 17 | 20141010 | 0 | ||
127576561 | 12757656 | 18 | 20141031 | 0 | ||
127576561 | 12757656 | 19 | 20141121 | 0 | ||
127576561 | 12757656 | 20 | 20141212 | 0 | ||
127576561 | 12757656 | 21 | 20150109 | 0 | ||
127576561 | 12757656 | 22 | 20150213 | 0 | ||
127576561 | 12757656 | 23 | 20150323 | 0 | ||
127576561 | 12757656 | 24 | 20150413 | 0 | ||
127576561 | 12757656 | 25 | 20150504 | 0 | ||
127576561 | 12757656 | 26 | 20150601 | 0 | ||
127576561 | 12757656 | 27 | 20150622 | 0 | ||
127576561 | 12757656 | 28 | 20150713 | 0 | ||
127576561 | 12757656 | 29 | 20150803 | 0 | ||
127576561 | 12757656 | 30 | 20150824 | 0 | ||
127576561 | 12757656 | 31 | 20150914 | 0 | ||
127576561 | 12757656 | 32 | 20151005 | 0 | ||
127576561 | 12757656 | 33 | 20151026 | 0 | ||
127576561 | 12757656 | 34 | 20151116 | 0 | ||
127576561 | 12757656 | 35 | 20151207 | 0 | ||
127576561 | 12757656 | 36 | 20151228 | 0 | ||
127576561 | 12757656 | 37 | 20160119 | 0 | ||
127576561 | 12757656 | 38 | 20160208 | 0 | ||
127576561 | 12757656 | 39 | 20160229 | 0 | ||
127576561 | 12757656 | 40 | 20160321 | 0 | ||
127576561 | 12757656 | 41 | 20160411 | 0 | ||
127576561 | 12757656 | 42 | 20160502 | 0 | ||
127576561 | 12757656 | 43 | 20130802 | 0 | ||
127576561 | 12757656 | 44 | 20130830 | 0 | ||
127576561 | 12757656 | 45 | 20130927 | 0 | ||
127576561 | 12757656 | 46 | 20131122 | 0 | ||
127576561 | 12757656 | 47 | 20131227 | 0 | ||
127576561 | 12757656 | 48 | 20130802 | 20131227 | 0 | |
127576561 | 12757656 | 49 | 20130802 | 20131227 | 0 |